Fidelity Investments’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-100
Closed -$234 5261
2022
Q4
$234 Sell
100
-720
-88% -$2.2K ﹤0.01% 4808
2022
Q3
$4K Sell
820
-2,875
-78% -$20.6K ﹤0.01% 4363
2022
Q2
$22K Buy
3,695
+3,621
+4,893% +$18.6K ﹤0.01% 3836
2022
Q1
$0 Buy
+74
New +$729 ﹤0.01% 4923

Other funds holding APYX

Fidelity Investments's APYX Position: Q1 2023 in Review

Fidelity Investments sold out of Apyx Medical (APYX) in Q1 2023, closing a stake of 100 shares — an estimated $234 sold.

Fidelity Investments first reported a position in APYX in Q1 2022 and held it in 4 quarters. The position peaked at $22K in Q2 2022. 55 funds tracked by Wall St. Rank hold APYX as of Q1 2023.

  • Fidelity Investments reported no remaining Apyx Medical position as of Q1 2023 after selling out during the quarter.
  • Fidelity Investments sold 100 Apyx Medical shares in Q1 2023, an estimated $234.
  • Fidelity Investments first reported a position in Apyx Medical in Q1 2022 and held it in 4 quarters.
  • Fidelity Investments's Apyx Medical position peaked at $22K in Q2 2022.
  • 55 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2023.

Based on Fidelity Investments's 13F filing for Q1 2023, filed 11 May 2023.